ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

331
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
05 Nov 2023 12:49

Korea Short Sell Ban: Background, Manipulation, Holdings, Flows, Short Interest, Implications

Media reports indicate that there could be a temporary short sell ban in Korea. This could lead to futures backwardation, market manipulation and a...

Logo
1k Views
Share
18 Nov 2024 07:05

KRX Foreign Holding Weekly (Nov 15th): Naver, Samsung Electronics

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Naver, Samsung Electronics.

Logo
189 Views
Share
bullishCelltrion Inc
11 Nov 2024 22:16

Celltrion Inc (068270 KS): Record High Sales in 3Q; Pipeline Progress Entails Long-Term Growth

​Celltrion reports 31% YoY revenue growth in 3Q24, driven by new products. The company is maintaining 2024 sales guidance of KRW3.5T (up 60% YoY),...

Logo
194 Views
Share
11 Nov 2024 07:05

KRX Foreign Holding Weekly (Nov 8th): Sk Hynix, Samsung Electronics, Samsung SDI, Hyundai Motor

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Sk Hynix, Samsung Electronics, Samsung SDI,...

Logo
370 Views
Share
06 Nov 2024 07:00

KRX Short Interest Weekly (Nov 1st): Hanwha Systems, HPSP, CSWIND

We analyzed KRX short interest report for the past week and highlighted short interest changes in Hanwha Systems, HPSP, CSWIND.

Logo
193 Views
Share
x